Background. The plasma levels of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are increased in relation to the severity of congestive heart failure (CHF). This study was designed to examine whether the secretion patterns of ANP and BNP vary with underlying cardiac disorders of CHF with different degrees of overload in atria and ventricles.
Methods and Results. We measured plasma levels of ANP and BNP in the aorta in 20 
Measurement of Plasma Levels ofANP and BNP
All blood samples were withdrawn into chilled plastic syringes and transferred to chilled siliconized disposable tubes that contained aprotinin (1.000 kallikrein inactivator units/ml) (Ohkura Pharmaceutical, Kyoto, Japan) and EDTA (1 mg/ml) and immediately placed on ice and centrifuged at 40C. An aliquot of plasma was immediately frozen at -800C and thawed only once at the time of extraction. Plasma ANP concentration was measured with a specific radioimmunoassay for a-human ANP as previously reported.30'31 This radioimmunoassay recognizes a carboxyterminal sequence of ANP, and the minimal detectable quantity of a-human ANP is 1 pg per tube. The intra-assay and interassay coefficients of variation were 7.2% and 7.8%, respectively. The cross-reactivity with human BNP was <0.01% on a molar basis. The plasma BNP concentration was measured with a specific radioimmunoassay using a monoclonal antibody that recognizes the ring structure of human BNP, as previously reported.23-25 Cross-reaction for a-human ANP was <0.005% on a molar basis. The intra-assay and interassay coefficients of variation were 8.4% and 6.4%, respectively.
Statistical Analysis
Hemodynamic parameters and plasma levels of ANP and BNP were compared among more than three groups using one-way ANOVA followed by Scheffe's test32 and between the MS and DCM groups in each stage of NYHA classification using the unpaired t test. The correlation of the plasma levels of ANP 
Results
Hemodynamic Study and Plasma Levels ofANP and BNP Table 1 shows the results of the hemodynamic study and the plasma levels of ANP and BNP. PCWP (mmHg) FIGURE 1. Scatterplots show correlations of pulmonary capillary wedge pressure (PCWP) with plasma levels ofatrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) in the mitral stenosis (MS) group and the dilated cardiomyopathy (DCM) group. There was a significant positive linear correlation between plasma ANP level and PCWP in both the MS and the DCM groups. However, a significant positive linear correlation was found between the plasma BNP level and PCWP only in the DCM group, and there was no significant correlation between the plasma BNP level and PCWP in the MS group. lation between the plasma BNP level and PCWP in the MS group (r=0.160, p=NS) (Figure 1 ). There was a significant positive linear correlation between the plasma ANP level and LVEDP in the DCM group (r=0.610, p<0.01) but not in the MS group (r=0.091, p=NS). There was a significant positive linear correlation between the plasma BNP level and LVEDP in the DCM group (r=O.591,p<0.01) but not in the MS group (r=0.143, p=NS) (Figure 2 ). There was a significant negative linear correlation between the plasma ANP level and LVEF in the DCM group (r= -0.457,p<0.05) but not in the MS group (r=0.089,p=NS). There was a significant negative linear correlation between the plasma BNP level and LVEF in the DCM group (r= -0.465, p<0.05) but not in the MS group (r=0.121, p=NS) (Figure 3 ). Table 2 shows the results of the multiple linear regression analysis. There was a significant correlation between the plasma BNP level and PCWP in the MS group as shown in however, no significant correlation between other combinations ( different degrees of overload in the atria and ventricles. In this study, we measured plasma levels of both ANP and BNP in patients with MS and in those with DCM. In the former, the atria are mainly overloaded, whereas in the latter, both the atria and the ventricles are overloaded, as indicated by the results of pressure study and ventriculography.
Multiple Linear Regression Analysis
In the stratification of patients by NYHA classification as shown in Table 1 , both plasma levels of ANP and BNP increased in relation to the severity of CHF in the DCM group. However, in the MS group, only the plasma ANP level increased in relation to the severity of CHF and not the plasma BNP level. There was no significant difference in PCWP between the MS and DCM groups, indicating that the degree of overload in the left atrium was comparable between the two groups. The plasma ANP level was also comparable between the MS and DCM groups. On the other hand, the plasma BNP level was much higher in the DCM group than in the MS group.
As shown in Figures 1-3 patients with MS and those with DCM, even though the MS group included not only the patients with pure MS but also those with MS combined grade I MR and AR.
Conclusions
The present study shows that underlying cardiac disorders of CHF with different degrees of overload in the atria and ventricles have different patterns of ANP and BNP secretion. The present results are also in agreement with our previous findings23-27 that BNP is a cardiac hormone secreted mainly from the ventricle.
